PaulJosephHampelMD

PubMed

• Prediction of outcomes for high-count monoclonal B lymphocytosis using an epigenetic and immunogenetic signature.
  Salma B Abdelbaky, Brian Giacopelli, Kari G Rabe, Kyoko Yamaguchi, Yue-Zhong Wu, Huihuang Yan, Tait D Shanafelt, Sameer A Parikh, Wei Ding, Paul J Hampel, Sochilt Brow...> ;Blood. 2024 Apr 25
• Rechallenge With High-Dose Methotrexate After Treatment With Glucarpidase in Adult Patients With Lymphoma.
  Truong, H., Barreto, J., Mara, K., Hampel, P., Micallef, I., Nowakowski, G., Thanarajasingam, G., Thompson, C., Wang, Y., Witzig, T., Herrmann, S., Leung, N.> ;JCO Oncology Practice. 2024 Feb 26
• Safety of radiotherapy for second primary malignancies in patients with chronic lymphocytic leukemia receiving concurrent novel agent treatment.
  Samuel R Kosydar, Sameer A Parikh, Scott C Lester, Kari G Rabe, Wei Ding, Jessica F Burlile, Saad S Kenderian, Yucai Wang, Eli Muchtar, Amber B Koehler, Susan M Schwag...> ;American Journal of Hematology. 2023 Nov 1
• BTKi bonanza in CLL/SLL: Sorting out the differences.
  Paul J Hampel, Sameer A Parikh> ;American Journal of Hematology. 2023 Apr 1
• 1 citations
  Correction: Chronic lymphocytic leukemia treatment algorithm 2022.
  Paul J Hampel, Sameer A Parikh> ;Blood Cancer Journal. 2022 Dec 22
• 10 citations
  Chronic lymphocytic leukemia treatment algorithm 2022.
  Paul J Hampel, Sameer A Parikh> ;Blood Cancer Journal. 2022 Nov 29
• 4 citations
  Clinical outcomes in patients with chronic lymphocytic leukemia with disease progression on ibrutinib.
  Paul J Hampel, Kari G Rabe, Timothy G Call, Wei Ding, Jose F Leis, Asher A Chanan-Khan, Saad S Kenderian, Eli Muchtar, Yucai Wang, Sikander Ailawadhi, Amber B Koehler,...> ;Blood Cancer Journal. 2022 Sep 1
• 6 citations
  Combined ibrutinib and venetoclax for treatment of patients with ibrutinib-resistant or double-refractory chronic lymphocytic leukaemia.
  Paul J Hampel, Kari G Rabe, Timothy G Call, Wei Ding, Jose F Leis, Saad S Kenderian, Eli Muchtar, Yucai Wang, Amber B Koehler, Ricardo Parrondo, Susan M Schwager, Min ...> ;British Journal of Haematology. 2022 Oct 1
• 22 citations
  CLL update 2022: A continuing evolution in care.
  Neil E Kay, Paul J Hampel, Daniel L Van Dyke, Sameer A Parikh> ;Blood Reviews. 2022 Jul 1
• 3 citations
  Isolated anemia in patients with large granular lymphocytic leukemia (LGLL).
  Youssef Salama, Fang Zhao, Jennifer L Oliveira, Ji Yuan, Dragan Jevremovic, Ronald S Go, Wei Ding, Sameer A Parikh, Mithun V Shah, Paul J Hampel, Aref Al-Kali, William...> ;Blood Cancer Journal. 2022 Feb 22
• 13 citations
  Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis.
  Eli Muchtar, Amber B. Koehler, Michael J. Johnson, Kari G. Rabe, Wei D Ding, Timothy G. Call, Jose F. Leis, Saad S. Kenderian, Suzanne R. Hayman, Yucai Wang, Paul J. H...> ;American Journal of Hematology. 2021 Oct 26
• 4 citations
  Immune-Related Hematologic Adverse Events in the Context of Immune Checkpoint Inhibitor Therapy
  Antoine N. Saliba, Zhuoer Xie, Alexandra Higgins, Xavier Andrade-Gonzalez, Harry E Fuentes-Bayne, Paul J. Hampel, Lionel A. Kankeu Fonkoua, Daniel S. Childs, Sagar Rak...> ;American Journal of Hematology. 2021 Jun 17
• 3 citations
  Epigenetic alteration contributes to the transcriptional reprogramming in T-cell prolymphocytic leukemia.
  Shulan Tian, Henan Zhang, Pan Zhang, Michael T Kalmbach, Jeong Heon Lee, Tamas Ordog, Paul J. Hampel, Timothy G. Call, Thomas E. Witzig, Neil E. Kay, Eric W. Klee, Sus...> ;Scientific Reports. 2021 Apr 15
• 1 citations
  The prognostic significance of del6q23 in chronic lymphocytic leukemia.
  Hadiyah Y. Audil, Paul J. Hampel, Daniel L. Van Dyke, Sara J. Achenbach, Kari G. Rabe, Stephanie A. Smoley, Timothy G. Call, Wei Ding, Min Shi, Curtis A. Hanson, Yucai...> ;American Journal of Hematology. 2021 Mar 22
• The significance of gradient expression of chromosome region maintenance protein 1 (exportin1) in large cell lymphoma.
  Jithma P. Abeykoon, Paul J. Hampel, Rebecca L. King, Adam J. Wood, Melissa C. Larson, Kevin E. Nowakowski, Saurabh Zanwar, Surendra Dasari, Gordon Ruan, Aishwarya Ravi...> ;Haematologica. 2021 Mar 4
• 6 citations
  Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia
  Paul J. Hampel, Sameer A. Parikh, Timothy G. Call, Mithun Vinod Shah, N. Nora Bennani, Aref Al-Kali, Kari G. Rabe, Yucai Wang, Eli Muchtar, Jose F. Leis, Saad S. Kende...> ;Blood Cancer Journal. 2021 Mar 2
• 2 citations
  Incorporating molecular biomarkers into the continuum of care in chronic lymphocytic leukemia.
  Paul J. Hampel, Sameer A. Parikh, Timothy G. Call> ;Leukemia & Lymphoma. 2021 Jan 7
• 17 citations
  Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia.
  Paul J. Hampel, Timothy G. Call, Kari G. Rabe, Wei Ding, Eli Muchtar, Saad S. Kenderian, Yucai Wang, Jose F. Leis, Thomas E. Witzig, Amber B. Koehler, Amie Fonder, Sus...> ;The Oncologist. 2020 Nov 1
• 12 citations
  Incidental Richter transformation in chronic lymphocytic leukemia patients during temporary interruption of ibrutinib.
  Paul J. Hampel, Hua Jay J. Cherng, Timothy G. Call, Wei Ding, Mahsa Khanlari, Ellen D. McPhail, Roberto N. Miranda, Pei Lin, Hussein Abdul-Hassan Tawbi, Alessandra Fer...> ;Blood Advances. 2020 Sep 22
• 13 citations
  Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice.
  Amber B. Koehler, Nelson Leung, Timothy G. Call, Kari G. Rabe, Sara J. Achenbach, Wei Ding, Saad S. Kenderian, Jose F. Leis, Yucai Wang, Eli Muchtar, Suzanne R. Hayman...> ;Leukemia & Lymphoma. 2020 May 25
• 7 citations
  Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare
  Paul J. Hampel, Timothy G. Call, Wei Ding, Eli Muchtar, Saad S. Kenderian, Yucai Wang, Jose F. Leis, Thomas E. Witzig, Amber B. Koehler, Amie Fonder, Susan M. Schwager...> ;American Journal of Hematology. 2020 Mar 1
• 40 citations
  Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice
  Paul J. Hampel, Wei Ding, Timothy G. Call, Kari G. Rabe, Saad S. Kenderian, Thomas E. Witzig, Eli Muchtar, Jose F. Leis, Asher Chanan-Khan, Amber B. Koehler, Amie Fond...> ;Leukemia & Lymphoma. 2019 Apr 24
• 33 citations
  Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre
  Paul J. Hampel, Melissa C. Larson, Brian Kabat, Timothy G. Call, Wei Ding, Saad S. Kenderian, Deborah J. Bowen, Justin C. Boysen, Susan M. Schwager, Jose F. Leis, Ashe...> ;British Journal of Haematology. 2018 Nov 1
• 7 citations
  Outcomes of endoscopic intervention for overt GI bleeding in severe thrombocytopenia.
  Guilherme Piovezani Ramos, Moritz Binder, Paul J. Hampel, Manuel Bonfim Braga Neto, Dharma Sunjaya, Badr F. Al Bawardy, Barham K. Abu Dayyeh, Navtej S. Buttar, David H...> ;Gastrointestinal Endoscopy. 2018 Jul 1
• 13 citations
  Outcomes of a large cohort of individuals with clinically ascertained high-count monoclonal B-cell lymphocytosis.
  Sameer A. Parikh, Kari G. Chaffee, Melissa C. Larson, Paul J. Hampel, Timothy G. Call, Wei Ding, Saad S. Kenderian, Jose F. Leis, Asher Chanan-Khan, Michael J. Conte, ...> ;Haematologica. 2018 Jun 1
• Join now to see all

Journal Articles

• Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukaemia Treated with Ibrutinib in Routine Clinical Practice at an Academic Medical Centre  
  Sameer A Parikh, Tait D Shanafelt, Paul J Hampel, Jose F Leis, Neil E Kay, Wei Ding, Timothy G Call, Deborah Bowen, Eli Muchtar, British Journal of Haematology

Lectures

• BTK and/or PLCG2 Mutations in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Ibrutinib: Characteristics and Outcomes at the Time of Progression 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Rapid progression of disease following ibrutinib discontinuation in patients with chronic lymphocytic leukemia. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018